MPH Health Care AG banner

MPH Health Care AG
XETRA:93M1

Watchlist Manager
MPH Health Care AG Logo
MPH Health Care AG
XETRA:93M1
Watchlist
Price: 21.7 EUR -2.69% Market Closed
Market Cap: €92.9m

Relative Value

The Relative Value of one 93M1 stock under the Base Case scenario is hidden EUR. Compared to the current market price of 21.7 EUR, MPH Health Care AG is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

93M1 Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

93M1 Competitors Multiples
MPH Health Care AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
MPH Health Care AG
XETRA:93M1
92.9m EUR 1 790.1 -0.8 -75.7 -73.1
US
Eli Lilly and Co
NYSE:LLY
947.5B USD 14.6 46.1 31.1 33.2
US
Johnson & Johnson
NYSE:JNJ
593.4B USD 6.3 22.2 15.4 18.9
CH
Roche Holding AG
SIX:ROG
282B CHF 4.6 29.9 12.7 14.8
CH
Novartis AG
SIX:NOVN
244.9B CHF 5.6 22.4 13.8 17.8
UK
AstraZeneca PLC
LSE:AZN
231.2B GBP 5.3 30.4 16.8 23.6
US
Merck & Co Inc
NYSE:MRK
298.6B USD 4.6 16.3 10.1 12.3
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 344.9 865
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK 3.4 10.2 7.6 8.9
US
Pfizer Inc
NYSE:PFE
151.7B USD 2.4 19.5 7.5 10
US
Bristol-Myers Squibb Co
NYSE:BMY
123.9B USD 2.6 17.6 7.4 9.1
P/E Multiple
Earnings Growth PEG
DE
MPH Health Care AG
XETRA:93M1
Average P/E: 23.8
Negative Multiple: -0.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
46.1
28%
1.6
US
Johnson & Johnson
NYSE:JNJ
22.2
7%
3.2
CH
Roche Holding AG
SIX:ROG
29.9
29%
1
CH
Novartis AG
SIX:NOVN
22.4
15%
1.5
UK
AstraZeneca PLC
LSE:AZN
30.4
26%
1.2
US
Merck & Co Inc
NYSE:MRK
16.3
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.2
7%
1.5
US
Pfizer Inc
NYSE:PFE
19.5
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
17.6
17%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DE
MPH Health Care AG
XETRA:93M1
Average EV/EBITDA: 46.7
Negative Multiple: -75.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
31.1
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
15.4
2%
7.7
CH
Roche Holding AG
SIX:ROG
12.7
5%
2.5
CH
Novartis AG
SIX:NOVN
13.8
5%
2.8
UK
AstraZeneca PLC
LSE:AZN
16.8
13%
1.3
US
Merck & Co Inc
NYSE:MRK
10.1
3%
3.4
IE
E
Endo International PLC
LSE:0Y5F
344.9
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
7.6
2%
3.8
US
Pfizer Inc
NYSE:PFE
7.5
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.4
-10%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DE
MPH Health Care AG
XETRA:93M1
Average EV/EBIT: 101.4
Negative Multiple: -73.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
33.2
22%
1.5
US
Johnson & Johnson
NYSE:JNJ
18.9
7%
2.7
CH
Roche Holding AG
SIX:ROG
14.8
6%
2.5
CH
Novartis AG
SIX:NOVN
17.8
9%
2
UK
AstraZeneca PLC
LSE:AZN
23.6
21%
1.1
US
Merck & Co Inc
NYSE:MRK
12.3
6%
2.1
IE
E
Endo International PLC
LSE:0Y5F
865
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8.9
3%
3
US
Pfizer Inc
NYSE:PFE
10
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
9.1
-7%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett